Concepedia

Shu Horiuchi

SH

Statistics

Publications

19

Citations

1.5K

H-Index

17

Active since

2010

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Weill Cornell Medicine

New York University

Cornell University

Chiba University

Shu Horiuchi is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, life sciences, and infectious diseases.

ORCID

Publications per year

2010–2025

19

Publications

19

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

Longlong Si, Haiqing Bai, Melissa Rodas et al. · Nature Biomedical Engineering · 2021 · 431 citations · Full text

, , +11

SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery

Justin J. Frere, Randal A. Serafini, Kerri D. Pryce et al. · Science Translational Medicine · 2022 · 242 citations · Full text

, , +17

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Daisy A. Hoagland, Rasmus Møller, Skyler Uhl et al. · Immunity · 2021 · 198 citations · Full text

, , +16

The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection

Kohei Oishi, Shu Horiuchi, Judith M. Minkoff et al. · Journal of Virology · 2022 · 71 citations · Full text

, , +17

The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets

Takuya Koike, Koshi Harada, Shu Horiuchi et al. · eLife · 2019 · 69 citations · Full text

, , +17

1–5 of 19